참고문헌
- Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer incidence, mortality, and prevalence worldwide. version 2.0 IARC Press. 2004.
- Bronowicki JP, Boudjem K, Chone L, et al. Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma. J Hepatol 1996;24:293-300. https://doi.org/10.1016/S0168-8278(96)80007-9
- Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocelluar carcinoma in 110 patients with cirrhosis. Ann Surg 2000;232:381-391. https://doi.org/10.1097/00000658-200009000-00010
- Song JW, Lee JG, Kim KS, Choi JS, Lee WJ, Kim BR. Combined hepatic resection and intraoperative radio-frequency ablation for multiple hepatocellular carcinoma. Korean J Hepatobiliary Pancreat Surg 2005;9:150-155.
- Jee SH, Ohrr H, Sull JW, Samet JM. Cigarette smoking, alcohol drinking, hepatitis B virus, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 2004;96:1851-1856. https://doi.org/10.1093/jnci/djh334
- Kubo S, Nishiguchi S, Hamba H, et al. Reactivation of viral replication after liver resection in patients infected with hepatitis B virus. Ann Surg 2001;233:139-145. https://doi.org/10.1097/00000658-200101000-00020
- Shuqun C, Mengchao W, Han C, et al. Antiviral therapy using lamivudine and thymosin alpha1 for hepatocellular carcinoma coexisting with chronic hepatitis B infection. Hepatogastroenterology 2006;53:249-252.
- Wands JR, Chura CM, Roll FJ, Maddrey WC. Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterology 1975;68:105- 112.
- Hoofnagle JH, Dusheiko GM, Schafer DF, et al. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 1982;96:447-449. https://doi.org/10.7326/0003-4819-96-4-447
- Thung SN, Gerber MA, Klion F, Gilbert H. Massive hepatic necrosis after chemotherapy withdrawal in a hepatitis B virus carrier. Arch Intern Med 1985;145:1313-1314. https://doi.org/10.1001/archinte.145.7.1313
- Pariente EA, Goudeau A, Dubois F, et al. Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation. Dig Dis Sci 1988; 33:1185-1191. https://doi.org/10.1007/BF01535798
- Bird GL, Smith H, Portmann B, Alexander GJ, Williams R. Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers. Q J Med 1989;73:895-902.
- Lau JY, Lai CL, Lin HJ, et al. Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients. Q J Med 1989;73:911-917.
- Flowers MA, Heathcote J, Wanless IR, et al. Fulminant hepatitis as a consequence of reactivation of hepatitis B virus infection after discontinuation of low-dose methotrexate therapy. Ann Intern Med 1990;112:381-382. https://doi.org/10.7326/0003-4819-112-5-381
- Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991;100:182-188. https://doi.org/10.1016/0016-5085(91)90599-G
- Yoshiba M, Sekiyama K, Sugata F, Okamoto H, Yamamoto K, Yotsumoto S. Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment. Dig Dis Sci 1992;37:1253-1259. https://doi.org/10.1007/BF01296569
- Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus related liver disease. Hepatology 1991;13: 619-626.
- O'Grady JG, Smith HM, Davies SE, et al. Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. J Hepatol 1992;14:104-111. https://doi.org/10.1016/0168-8278(92)90138-F
- Roche B, Samuel D. Evolving strategies to prevent HBV recurrence. Liver Transpl 2004;10(10 Suppl 2):S74-85.
- Wilmore DW. Homeostasis: bodily changes in trauma and surgery. In: Sabiston DG Jr. Textbook of Surgery. 45th ed. Philadelphia: WB Saunders; 1997.55-67.
- Villeneuve JP, Condreay LD, Willems B, et al. Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology 2000;31:207-210. https://doi.org/10.1002/hep.510310130
- Lo CM, Cheung ST, Lai CL, et al. Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis. Ann Surg 2001;233:276-281. https://doi.org/10.1097/00000658-200102000-00018
- Perrillo RP, Wright T, Rakela J, et al. A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after transplantation for chronic hepatitis B. Hepatology 2001;33:424-432. https://doi.org/10.1053/jhep.2001.21554
- Yao FY, Terrault NA, Freise C, Maslow L, Bass NM. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort. Hepatology 2001;34: 411-416. https://doi.org/10.1053/jhep.2001.26512
- Fontana RJ, Hann HW, Perrillo RP, et al. Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy. Gastroenterology 2002;123:719-727. https://doi.org/10.1053/gast.2002.35352